Kelly N. Wright
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kelly N. Wright has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Matthew T. Siedhoff
Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, United States
14 shared publications - Rebecca J. Schneyer
Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, United States
7 shared publications - Mireille Truong
Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA
6 shared publications - Raanan Meyer
Cedars Sinai Medical Center, Department of Obstetrics and Gynecology, Division of Minimally Invasive Gynecologic Surgery, Los Angeles, CA, USA
6 shared publications Kacey M. Hamilton
Department of Obstetrics and Gynecology Cedars‐Sinai Medical Center Los Angeles California USA
4 shared publications- Gabriel Levin
McGill University, McGill University Health Center, Division of Gynecologic Oncology, Montreal, QC, Canada
3 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
The Probe Leads the Scalpel—A New Dimension to Gynaecology Care
- 30 October 2026
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
Open AccessThe Probe Leads the Scalpel—A New Dimension to Gynaecology Care
- 6 July 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , 1063-1072
Standard vs lower pressure pneumoperitoneum in laparoscopic gynecologic surgery: a randomized controlled trial
- 6 July 2026
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 235 (5) , 1063-1072
Standard vs lower pressure pneumoperitoneum in laparoscopic gynecologic surgery: a randomized controlled trial
- Open Access
- 21 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 869
Routine Ketorolac Use for Postoperative Pain Does Not Increase Bleeding Risk After Hysterectomy
Background/Objective: Ketorolac is an effective alternative and addition to opioids for postoperative pain control; however, there is concern of perioperative bleeding risk with its use. Within gynecology, this risk has not yet been explored in the context of hysterectomy. This study aimed to evaluate the risk of postoperative bleeding complications with ketorolac administration in the context of hysterectomy. Methods: This was a retrospective cohort study that included all patients who underwent hysterectomy for benign indications between 2015 and 2024 at a quaternary care academic hospital. Inclusion criteria were any type of hysterectomy during the study period, while exclusion criteria were malignancy and peripartum status. Complication data for up to thirty days post operation were collected. Multivariable regression analysis, including age, American Society of Anesthesiology category, use of celecoxib before surgery, anticoagulant treatment, uterus size, surgical approach, increased surgical complexity, and lysis of adhesions, was performed to identify the adjusted odds of postoperative bleeding complications. The primary outcome was a composite of any postoperative bleeding complications by use of postoperative ketorolac, including postoperative transfusion, readmission, or reoperation for bleeding. Results: In total, 4236 patients underwent hysterectomy for benign indications during our study period, of which 76% (n = 3236) received ketorolac postoperatively. The composite postoperative bleeding rate was lower in the ketorolac group (2.1% vs. 4.1%, p = 0.001). There was no association between ketorolac use and risk of postoperative bleeding in multivariable regression analysis (aOR 1.02, 95% CI 0.36–2.88). There was no difference in overall intraoperative or perioperative complications (p = 0.070 for both). Major perioperative complications were less likely in the ketorolac group (p = 0.046). Additionally, there were no differences in postoperative complications except for ileus, which was less likely in the ketorolac group (p = 0.034). Conclusions: Ketorolac administration was not associated with a higher risk of bleeding complications after hysterectomy, including when celecoxib was used preoperatively as part of an enhanced recovery protocol. It may safely be administered as an opioid-sparing pain medication in this setting.
- 21 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 869
Open AccessRoutine Ketorolac Use for Postoperative Pain Does Not Increase Bleeding Risk After Hysterectomy
Background/Objective: Ketorolac is an effective alternative and addition to opioids for postoperative pain control; however, there is concern of perioperative bleeding risk with its use. Within gynecology, this risk has not yet been explored in the context of hysterectomy. This study aimed to evaluate the risk of postoperative bleeding complications with ketorolac administration in the context of hysterectomy. Methods: This was a retrospective cohort study that included all patients who underwent hysterectomy for benign indications between 2015 and 2024 at a quaternary care academic hospital. Inclusion criteria were any type of hysterectomy during the study period, while exclusion criteria were malignancy and peripartum status. Complication data for up to thirty days post operation were collected. Multivariable regression analysis, including age, American Society of Anesthesiology category, use of celecoxib before surgery, anticoagulant treatment, uterus size, surgical approach, increased surgical complexity, and lysis of adhesions, was performed to identify the adjusted odds of postoperative bleeding complications. The primary outcome was a composite of any postoperative bleeding complications by use of postoperative ketorolac, including postoperative transfusion, readmission, or reoperation for bleeding. Results: In total, 4236 patients underwent hysterectomy for benign indications during our study period, of which 76% (n = 3236) received ketorolac postoperatively. The composite postoperative bleeding rate was lower in the ketorolac group (2.1% vs. 4.1%, p = 0.001). There was no association between ketorolac use and risk of postoperative bleeding in multivariable regression analysis (aOR 1.02, 95% CI 0.36–2.88). There was no difference in overall intraoperative or perioperative complications (p = 0.070 for both). Major perioperative complications were less likely in the ketorolac group (p = 0.046). Additionally, there were no differences in postoperative complications except for ileus, which was less likely in the ketorolac group (p = 0.034). Conclusions: Ketorolac administration was not associated with a higher risk of bleeding complications after hysterectomy, including when celecoxib was used preoperatively as part of an enhanced recovery protocol. It may safely be administered as an opioid-sparing pain medication in this setting.
- Open Access
- 5 November 2025
- Published by Elsevier in The Journal of Climate Change and Health
- Vol. 26, 100553
Reducing regulated medical waste: A roadmap for process improvement
- 5 November 2025
- Published by Elsevier in The Journal of Climate Change and Health
- Vol. 26, 100553
Open AccessReducing regulated medical waste: A roadmap for process improvement
- Open Access
Examining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial Neoplasia
Objective: We aimed to study the association of patient’s body mass index (BMI) with postoperative complications in patients surgically treated for endometrial intraepithelial neoplasia, with and without sentinel lymph node biopsy. Methods: A cohort study using the prospective National Surgical Quality Improvement Program database. Women with endometrial intraepithelial neoplasia on postoperative pathology who underwent minimally invasive hysterectomy from January 2012 to December 2020 were included. The cohort was dichotomized based on the performance of sentinel lymph node biopsy. We analyzed postoperative complications based on the World Health Organization (WHO) categories of BMI. Results: A total of 4428 patients met the inclusion criteria. Of those, 584 (13.2%) had sentinel lymph node biopsy. Overall, 76.5% of patients (n = 3389) were obese (BMI > 30.0), with 1840 (41.6%) patients of BMI ≥ 40.0. The rate of any complications was 6.0% (n = 264), major complications 2.3% (n = 101), and minor complications 4.2% (n = 187). When comparing the rate of any complications between patients who had sentinel lymph node biopsy vs. those without a sentinel lymph node biopsy procedure, stratified by BMI category, there was no association between sentinel lymph node biopsy performance and any complications in any of the BMI categories. In a multivariable binary regression analysis, BMI and the performance of sentinel lymph node biopsy were not independently associated with any complication [adjusted odds ratio (aORs) 1.001, 95% confidence interval (CI) (0.98–1.01), and aORs 1.1, 95% CI (0.82–1.65), respectively]. In an analysis of the cohort of patients who underwent sentinel lymph node biopsy, there was no association between the rates of any major or minor complications with BMI categories or obesity. ROC analyses for the association between BMI and occurrence of any major or minor complications had a low performance. Conclusions: In minimally invasive surgery for endometrial intraepithelial neoplasia, there is no association between body mass index and increased risk for postoperative complications when performing hysterectomy with sentinel lymph node biopsy versus hysterectomy alone.
Open AccessExamining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial Neoplasia
Objective: We aimed to study the association of patient’s body mass index (BMI) with postoperative complications in patients surgically treated for endometrial intraepithelial neoplasia, with and without sentinel lymph node biopsy. Methods: A cohort study using the prospective National Surgical Quality Improvement Program database. Women with endometrial intraepithelial neoplasia on postoperative pathology who underwent minimally invasive hysterectomy from January 2012 to December 2020 were included. The cohort was dichotomized based on the performance of sentinel lymph node biopsy. We analyzed postoperative complications based on the World Health Organization (WHO) categories of BMI. Results: A total of 4428 patients met the inclusion criteria. Of those, 584 (13.2%) had sentinel lymph node biopsy. Overall, 76.5% of patients (n = 3389) were obese (BMI > 30.0), with 1840 (41.6%) patients of BMI ≥ 40.0. The rate of any complications was 6.0% (n = 264), major complications 2.3% (n = 101), and minor complications 4.2% (n = 187). When comparing the rate of any complications between patients who had sentinel lymph node biopsy vs. those without a sentinel lymph node biopsy procedure, stratified by BMI category, there was no association between sentinel lymph node biopsy performance and any complications in any of the BMI categories. In a multivariable binary regression analysis, BMI and the performance of sentinel lymph node biopsy were not independently associated with any complication [adjusted odds ratio (aORs) 1.001, 95% confidence interval (CI) (0.98–1.01), and aORs 1.1, 95% CI (0.82–1.65), respectively]. In an analysis of the cohort of patients who underwent sentinel lymph node biopsy, there was no association between the rates of any major or minor complications with BMI categories or obesity. ROC analyses for the association between BMI and occurrence of any major or minor complications had a low performance. Conclusions: In minimally invasive surgery for endometrial intraepithelial neoplasia, there is no association between body mass index and increased risk for postoperative complications when performing hysterectomy with sentinel lymph node biopsy versus hysterectomy alone.
- 2 December 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (3) , 220-228
The Impact of Minimally Invasive Gynecologic Surgery Subspecialty Training on Outcomes of Myomectomy: A Retrospective Cohort Study
- 2 December 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (3) , 220-228
The Impact of Minimally Invasive Gynecologic Surgery Subspecialty Training on Outcomes of Myomectomy: A Retrospective Cohort Study
- 28 November 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (5) , 425-431
The Impact of Exclusively Virtual Preoperative Evaluation on Complications of Gynecologic Surgery
- 28 November 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (5) , 425-431
The Impact of Exclusively Virtual Preoperative Evaluation on Complications of Gynecologic Surgery
- Open Access
- 13 October 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (12) , 108761
Risk factors for major complications following pelvic exenteration: A NSQIP study
- 13 October 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (12) , 108761
Open AccessRisk factors for major complications following pelvic exenteration: A NSQIP study